Moser, R.* et al. Assessment of the impact of age on DIBH in radiotherapy based on the prospective GATTUM and B-REST trials. Clin. Transl. Radiat. Oncol. 53:100956 (2025)
Behzadi, S.T.* et al. Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy. Clin. Transl. Radiat. Oncol. 48:100831 (2024)
Bodensohn, R.* et al. Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12). Clin. Transl. Radiat. Oncol. 45:100706 (2024)
Felchle, H.* et al. Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors. Clin. Transl. Radiat. Oncol. 46:100758 (2024)
Unger, K. et al. DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score. Clin. Transl. Radiat. Oncol. 39:100586 (2023)
Thomsen, A.R.* et al. Biopsy-derived oral keratinocytes – A model to potentially test for oral mucosa radiation sensitivity. Clin. Transl. Radiat. Oncol. 34, 51-56 (2022)
Rabasco Meneghetti, A.* et al. Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma. Clin. Transl. Radiat. Oncol. 26, 62-70 (2021)
Kessel, K.A. et al. Cancer clinical trials – Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC). Clin. Transl. Radiat. Oncol. 13, 44-49 (2018)